| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Revenue | $12.9B | $11.3B |
| Cost of Revenue | — | — |
| Gross Profit | $1.5B | $1.6B |
| R&D Expense | — | — |
| SG&A Expense | $1.2B | $1.4B |
| Operating Income | $0.3B | $0.2B |
| Net Income | $0.2B | $-0.0B |
| EPS (Basic) | $0.94 | $-0.09 |
| EPS (Diluted) | $0.87 | $-0.09 |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Total Assets | $6.4B | $5.9B |
| Current Assets | $2.9B | $1.9B |
| Cash & Equivalents | $0.1B | $0.1B |
| Total Liabilities | $4.5B | $4.3B |
| Current Liabilities | $1.8B | $1.4B |
| Stockholders' Equity | $1.9B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Operating Cash Flow | $0.5B | $0.0B |
| Investing Cash Flow | $-0.3B | $-0.1B |
| Capital Expenditures | $0.1B | $0.1B |
| Financing Cash Flow | $-0.2B | $0.2B |